Chronic Diseases | Kisaco Research

Women Living Well at WHIS: Chronic and Non-Communicable Diseases

Chronic conditions and non-communicable diseases are the number one public health concern as of 2024. Chronic conditions such as cardiovascular disease, osteoporosis and autoimmune disorders like lupus and behavioural health will account for 86% of all deaths each year by 2050 according to the UN. Despite living longer than men, women are disproportionately affected by non-communicable diseases, spending more of their lifetime living in poor health than men. This is exasperated further by a lack of sex and gender-specific research.

WHIS USA is on a mission to change this, by highlighting the critical role that sex and gender play in these key areas. We’re committed to demonstrating how diagnostics, therapeutics, and preventative care options with sex and gender in mind will significantly improve health outcomes for 50%+ of the population.

Content Covered

Join us at WHIS on 23-25 September in Boston where we will provide you with the roadmap to success in the chronic disease space:

  1. Capitalize on guidelines calling for more sex and gender specific research by understanding how better diversity and inclusion in clinical trials will better stimulate research and innovation.

  2. Harness the role of AI in data capturing from industry giants such as Google.

  3. Look at the future of chronic health during research and innovation sessions addressing the most promising areas improving outcomes for women.

View The Agenda


Wednesday, 25 Sep, 2024
9:40am - 10:20am

With an increase in publishing guidelines calling for more sex and gender specific research and better diversity and inclusion in clinical trials, this panel discussion considers how to promote accountability across the public and private sphere. How can we ensure that guidelines are adhered to and what role do public-private sector partnerships play in promoting better research practices? What do recent guidelines published by the FDA advocating for health equity in clinical trials really mean for those innovation in the space? Join this session to unpack these questions and to gain insight into how to ensure your business is successfully considering sex and gender throughout the R&D process.

Author:

Hadine Joffee

MD, MSc, Interim Chair, Department of Psychiatry, Executive Director, Mary Horrigan Connors Center for Women's Health and Gender Biology
Brigham and Women’s Hospital & Harvard Medical School

Hadine Joffee

MD, MSc, Interim Chair, Department of Psychiatry, Executive Director, Mary Horrigan Connors Center for Women's Health and Gender Biology
Brigham and Women’s Hospital & Harvard Medical School
2:10pm - 2:40pm

Join this session to learn about how recent understandings of the ways that women present differently from men in various disease areas have impacted the delivery and design of clinical trials to account for sex differences. Hear about the latest innovations driving change, including the role that AI and ML play in stratifying populations, and how remote clinical trials and telehealth are increasing access to clinical trials. Both of these factors play a crucial role in ensuring that more diversity and sex-focused trials take place

Author:

Lisa Suennen

Managing Partner, AHA Ventures
American Heart Association

Lisa Suennen

Managing Partner, AHA Ventures
American Heart Association

This presentation takes a look at an area of women’s health where AI and technology have had a profound impact in increasing access and improving outcomes through next generation imaging. Hear from experts leading the way as they unpack the latest developments and discuss it’s potential to transform women’s cancer outcomes

Author:

Jennifer Schneiders

President Diagnostic Solutions
Hologic

Jennifer Schneiders

President Diagnostic Solutions
Hologic
2:40pm - 3:10pm

There have been huge advancements in generative AI in recent years. But how do we leverage this in women’s consumer health? Join this exciting discussion to hear about the role that Generative AI will play in creating customized, personalized, and precise wellness plans based on individual health data. Learn about the opportunity to positively impact women at different phases of their menstrual cycle.

Author:

Nichole YoungLin

MD, MBA, Women’s Health Clinical Lead
Google

Nichole YoungLin

MD, MBA, Women’s Health Clinical Lead
Google
3:10pm - 3:50pm

As many as 4 out of 5 people with an autoimmune disease are women. The question of why has plagued researchers for years. New research, however, is shedding the light on this age-old mystery for the first time. Join this presentation to hear more about this research and learn about how chromosomes play an important role in determining sex and gender differences. Consider what this means for innovation, and how it will impact other areas of women’s health. 

4:20pm - 4:50pm

This session homes in on a health condition that affects women at a significantly higher rate than men. Taking a 360 look at the latest insights and developments, this session covers innovative solutions that look to prevent osteoporosis, as well as those that look to manage the condition and novel research looking to address the root cause.

Author:

Anula Jayasuriya

Co-Founder
Kidron Capital

Anula Jayasuriya

Co-Founder
Kidron Capital
4:50pm - 5:20pm

AI presents an exciting opportunity to augment behavioural health delivery by enhancing access to care. Join this session to hear from those innovating at the forefront of this disruptive space as they outline the opportunities to improve women’s mental health.

Moderator

Author:

Jasmi Shah

Managing Director
Cigna Ventures

Jasmi Shah

Managing Director
Cigna Ventures

Author:

Brianna Brennan

Chief Innovation Officer
Ontrak Health

Brianna Brennan

Chief Innovation Officer
Ontrak Health

Author:

Tamika Lane, MSN, RN, CCM

Director, Clinical Innovation and Client Relationships
Sentara Health Plans

Tamika Lane, MSN, RN, CCM

Director, Clinical Innovation and Client Relationships
Sentara Health Plans

Attendees Joining us include: